CYRX:NSD-Cryoport Inc (USD)

COMMON STOCK | Integrated Freight & Logistics |

Last Closing

USD 7

Change

0.00 (0.00)%

Market Cap

USD 0.30B

Volume

0.62M

Analyst Target

USD 23.63
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and cryogenic biostorage within the life science industry. Its Life Sciences Products segment offers cryogenic freezers, cryogenic dewars, and accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport ELITE Shippers; Cryoport Express Cryogenic HV3 Shipping System; Smartpak II Condition Monitoring System and Tec4Med; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as CRYOGENE, a biostorage solution for the provision of pre-clinical temperature-controlled biological materials management services; and Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; CRYOPDP, a temperature-controlled logistics solution; MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; and Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-07 )

Largest Industry Peers for Integrated Freight & Logistics

Symbol Name Price(Change) Market Cap
EXPD Expeditors International of Wa..

N/A

USD 15.44B
JBHT JB Hunt Transport Services Inc

N/A

USD 13.77B
CHRW CH Robinson Worldwide Inc

N/A

USD 10.56B
LSTR Landstar System Inc

N/A

USD 4.76B
HUBG Hub Group Inc

N/A

USD 2.04B
FLX BingEx Ltd

N/A

USD 0.62B
FWRD Forward Air Corporation

N/A

USD 0.50B
CRGO Freightos Limited Ordinary sha..

N/A

USD 0.11B
SFWL Shengfeng Development Limited ..

N/A

USD 0.08B
BTOC Armlogi Holding Corp. Common S..

N/A

USD 0.07B

ETFs Containing CYRX

N/A

Market Performance

  Market Performance vs. Industry/Classification (Integrated Freight & Logistics) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -10.03% 76% C+ 39% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -10.03% 76% C+ 38% F
Trailing 12 Months  
Capital Gain -36.94% 17% F 24% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -36.94% 17% F 24% F
Trailing 5 Years  
Capital Gain -73.09% 25% F 19% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -73.09% 25% F 18% F
Average Annual (5 Year Horizon)  
Capital Gain -4.37% 73% C 32% F
Dividend Return -4.37% 73% C 30% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 140.79% 18% F 14% F
Risk Adjusted Return -3.10% 73% C 37% F
Market Capitalization 0.30B 61% D- 55% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector